Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Amkay Products IPO
Price Band
₹52.0–55.0
Issue Size
₹12.61 Cr
Lot Size
2,000 shares
Min Investment
₹110,000
GMP
+₹62.0 (112.73%)
Issue Price
₹55.0
Subject to Sauda
₹94200
Paid only if allotted
Amkay Products IPO AI Summary
- Amkay Products IPO is listed on BSE SME in the Medical Equipment & Supplies sector.
- Price band: ₹52.0–₹55.0 per share, lot size 2,000 shares (min. investment ₹110,000).
- Subscription window: 30 Apr–03 May 2024, listing on 08 May 2024.
- Current GMP is +₹62.0 (112.73%), an estimated listing price of ₹117 — unofficial and can change daily.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Amkay Products IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 03 May 2024 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Amkay Products IPO Grey Market Premium (GMP) Today
GMP
+₹62.0
GMP %
+112.73%
Est. Listing
₹117.0
Updated: 25 Jul 2026 14:06
About the Company
Incorporated in October 2007, Amkay Products Limited is a company that produces and sells a wide range of healthcare products including medical devices, disposables, and other essential items such as face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, surgeon caps, and more. Their products are used by healthcare centers, hospitals/clinics, nursing homes, and other such facilities across India. The company manufactures and markets products such as diapers, plastic gloves, and suction machines. The company offers over 30 healthcare products, including medical devices for respiratory diseases, surgical disposables, home healthcare products, and others. We manufacture 20 products and brand/trade 10 others. The manufacturing facility, which occupies an area of about 26000 sq. ft., is fully equipped with machines, a testing lab, and other handling equipment to ensure a smooth process. The company is also accredited under the ISO 9001:2015 standard by QRO Certification LLP for its quality management system. The company has two manufacturing unit situated in Thane, Maharashtra and a Wearhouse situated in Thane Maharastra. As of December 31, 2023, the company has employed about 75 employees across different levels of the organization.
Company Financials (₹ Cr)
As of 2023-12-31
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 18.88 | 15.64 | 15.81 | 13.93 |
| Total Income | 23.86 | 28.25 | 36.79 | 40.72 |
| Profit After Tax | 2.15 | 1.51 | 1.47 | 3.13 |
| NET Worth | 9.87 | 7.72 | 6.21 | 4.74 |
| Reserves and Surplus | 3.51 | 7.44 | 5.93 | 4.46 |
| Total Borrowing | 4.76 | 4.70 | 4.34 | 1.37 |
Key Ratios
EPS
₹2.37
NAV
₹15.51
ROE
24.49%
ROCE
21.54%
RoNW
21.82%
P/B Value
3.55
P/E Ratio
23.18
Market Cap
₹47.61 Cr
PAT Margin
9.47%
Debt/Equity
0.48
Peer Comparison
| Company | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|
| Qms Medical Allied Services Limited | 9.06% | 26.53 | 3.9 | 3.9 |
| Hemant Surgical Industries Ltd | 32.42% | 14.59 | 10.28 | 10.28 |
| Amkay Products Limited This IPO | 19.57% | — | 2.37 | 2.37 |
Promoters
Kashyap Pravin Mody and Himanshu Kantilal Batavia
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding Capital Expenditure towards installation of additional Machinery 0.50 2 To meet working capital requirements 8.00 3 General Corporate Purpose 2.59
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹36.79 Cr in the year ending 31 Mar 2022, which decreased to ₹28.25 Cr by 31 Mar 2023, and further dropped to ₹23.86 Cr as of 31 Dec 2023, though this is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit After Tax was ₹1.47 Cr in the year ending 31 Mar 2022, increasing to ₹1.51 Cr by 31 Mar 2023, and then rising to ₹2.15 Cr as of 31 Dec 2023, though this is a 9-month figure, not a full year, so isn't directly comparable.
Valuation
Amkay Products Limited has an implied P/E ratio of approximately 23.18 at the issue price, while peers are trading with P/E ratios ranging from 14.59 to 26.53.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on unofficial trading before it officially lists on the stock exchange. A positive GMP suggests that the stock may list at a higher price than the issue price, reflecting investor demand.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their investment goals and risk tolerance. It's essential to consider the company's fundamentals and market conditions before making a decision.
Who May Want to Wait
Investors who prefer stable returns and are risk-averse may want to avoid IPOs like this, as they can be subject to market fluctuations and may not provide immediate returns.
IPO Timeline, Explained
The IPO process includes several key dates: the issue opens on April 30, 2024, and closes on May 3, 2024. Allotment of shares is expected by May 6, 2024, with the listing date set for May 8, 2024.
Listing Gains — The Risk
Listing gains refer to the profit made when an IPO's shares are sold on the listing day at a price higher than the issue price. However, these gains are not guaranteed and can be influenced by market conditions and investor sentiment. It's important to understand that prices can fluctuate significantly after listing.
This evaluation is generated from Amkay Products's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Amkay Products IPO GMP today?
Amkay Products IPO GMP today is +₹62.0 (112.73%), indicating an estimated listing price of ₹117. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Amkay Products IPO?
The price band of Amkay Products IPO is ₹52.0–₹55.0 per share.
When does Amkay Products IPO open and close?
Amkay Products IPO opens on 30 April 2024 and closes on 03 May 2024.
When does Amkay Products IPO list on the stock exchange?
Amkay Products IPO listed on 08 May 2024 at ₹117.0.
What is the lot size for Amkay Products IPO?
The lot size for Amkay Products IPO is 2000 shares, requiring a minimum investment of ₹110,000.
What is the price band for the Amkay Products IPO?
The price band for the Amkay Products IPO is ₹52.0 to ₹55.0.
What is the minimum investment required for the Amkay Products IPO?
The minimum investment required is ₹110,000, which corresponds to a lot size of 2000 shares.
When does the Amkay Products IPO open and close?
The IPO opens on April 30, 2024, and closes on May 3, 2024.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of an IPO based on unofficial trading before it officially lists.
When is the listing date for the Amkay Products IPO?
The listing date for the Amkay Products IPO is scheduled for May 8, 2024.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
30 Apr 2024
Close
03 May 2024
Allotment
06 May 2024
Listing
08 May 2024
Similar IPOs in Medical Equipment & Supplies
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Amkay Products?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.